Nuzenio

Companion Diagnostic Test

Companion Diagnostic Test news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 8 publisher sources 100/100 entity strength

Latest news

FDA Approves Labcorp Companion Diagnostic for Advanced Melanoma - Clinical Lab ProductsClinical Lab Products · Mon, 10 Aug 2026 19:06:57 GMT US FDA Approves LabCorp’s Companion Diagnostic Test for Advanced Melanoma: Here’s What To Know - thedermdigest.comthedermdigest.com · Mon, 10 Aug 2026 18:14:33 GMT For advanced melanoma, Labcorp's test supports access to targeted therapies - Stock TitanStock Titan · Mon, 10 Aug 2026 11:00:00 GMT CellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 11:00:39 GMT Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - BioSpaceBioSpace · Thu, 06 Aug 2026 03:07:25 GMT Labcorp Launches FDA-Approved IHC Companion Diagnostic for Prostate Cancer - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMT SOPHiA GENETICS and AstraZeneca Collaborate to Develop Oncology Companion Diagnostics - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMT Signatera Is Submitted to Japan's PMDA for Companion Diagnostic Approval in MIBC - OncLiveOncLive · Wed, 05 Aug 2026 15:09:02 GMT

Timeline

Mon, 10 Aug 2026 19:06:57 GMTFDA Approves Labcorp Companion Diagnostic for Advanced Melanoma - Clinical Lab Products

Mon, 10 Aug 2026 18:14:33 GMTUS FDA Approves LabCorp’s Companion Diagnostic Test for Advanced Melanoma: Here’s What To Know - thedermdigest.com

Mon, 10 Aug 2026 11:00:00 GMTFor advanced melanoma, Labcorp's test supports access to targeted therapies - Stock Titan

Fri, 07 Aug 2026 11:00:39 GMTCellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing Chemist

Thu, 06 Aug 2026 03:07:25 GMTNatera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - BioSpace

Wed, 05 Aug 2026 20:52:25 GMTLabcorp Launches FDA-Approved IHC Companion Diagnostic for Prostate Cancer - Clinical Lab Products

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Japan5 live mentions Companion Diagnostic4 live mentions PMDA4 live mentions Diagnostic4 live mentions Advanced Melanoma3 live mentions Clinical Lab Products3 live mentions Labcorp Launches FDA3 live mentions FDA Approves Labcorp2 live mentions Lab Products Clinical2 live mentions Lab Products2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Companion Diagnostic Test.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.